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Bioequivalence and Statistics in Clinical Pharmacology, Scott Patterson and Byron Jones, Chapman & Hall/CRC, 2006, 1-58488-530-0, $97.95, xxi + 374 pages.

The book provides an introduction to statistics used in clinical pharmacology by walking a fine line between providing the reader with details on statistical concepts and methods, giving hands on examples and discussing the relevant regulatory framework. As a consequence the reader must have a basic understanding of statistics and the drug development process to benefit from this book. Given this knowledge, however, the book provides a good introduction to common uses of statistics in early phases of the drug development process using a good mix of technical detail, intuitive understanding and factual knowledge. The in-depth familiarity and understanding of the subject by the authors shows throughout the book. This, on the one hand leads to some very interesting, often overlooked, points being highlighted and discussed (eg efficiencies of different orderings in multi-period designs, Chapter 4) while on the other they loose themselves in marginal points (eg history of bioequivalence guidelines, Chapter 6) on occasion. 

A unique feature of the book are the experiences/recollections by Scott Patterson at the beginning of each chapter in which he provides the reader with humorously written personal accounts relating to the topic to be discussed from his professional life. These personal accounts together with the numerous real data examples which are accompanied by SAS code for analysis and the opportunity to download the data to gain first hand experience are the best features of the book. Unfortunately, however, the books typesetting is, to put it bluntly, horrible, especially in its early chapters. The typesetting issues include hyphenation (eg “n-ext”), misplaced paragraph breaks and distorted pictures and are in places making the book difficult to read. 

Overall, however, the authors did a fine job in providing an introduction to statistics in the early stages of the drug development process. The availability of real example data allows the reader to engage himself easily in the topic and the yearlong experience of the authors ensures that many different aspects of pharmacological studies are discussed.  
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